A post-authorisation safety study of ABRYSVO in immunocompromised, or renally or hepatically impaired adults aged 60 years and older in a real world setting in Europe and UK (C3671038)

First published 21/02/2025

Last updated 06/11/2025

EU PAS number:

EUPAS1000000400

Study

Ongoing

Documents

Study protocol

Initial protocol

C3671038_RSV VACCINE OLDER ADULT PROTOCOL V1.0_09JUL2024.pdf

English (1016.93 KB - PDF) View document

Updated protocol

C3671038_RSV VACCINE OLDER ADULT UPDATED PROTOCOL V2.0_07OCT2024.pdf

First published: 19/02/2025

English (1 MB - PDF) View document

Study results

Study report

c3671038-progress-report1-report-body.pdf

English (1.18 MB - PDF) View document

Other information

Secondary tabs